Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in TPAIT for chronic pancreatitis
NCT03283566Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Oct 2017
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in chronic pancreatitis (CP), sponsored by Cleveland Clinic. Started Oct 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT03283566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283566.